661 related articles for article (PubMed ID: 22437415)
1. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
[TBL] [Abstract][Full Text] [Related]
2. A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.
Manns B; Tonelli M; Culleton B; Faris P; McLaughlin K; Chin R; Gooch K; McAlister FA; Taub K; Thorlacius L; Krause R; Kearns M; Hemmelgarn B;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):565-72. PubMed ID: 22344504
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
Turgut F; Balogun RA; Abdel-Rahman EM
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
[TBL] [Abstract][Full Text] [Related]
4. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
[TBL] [Abstract][Full Text] [Related]
5. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease.
Mitobe M; Yoshida T; Sugiura H; Shiohira S; Shimada K; Nitta K; Tsuchiya K
Clin Exp Nephrol; 2010 Dec; 14(6):573-7. PubMed ID: 20700620
[TBL] [Abstract][Full Text] [Related]
7. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
[TBL] [Abstract][Full Text] [Related]
8. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
Yildirim T; Arici M; Piskinpasa S; Aybal-Kutlugun A; Yilmaz R; Altun B; Erdem Y; Turgan C
Ren Fail; 2012; 34(9):1095-9. PubMed ID: 22950572
[TBL] [Abstract][Full Text] [Related]
9. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
11. A Population-Based Analysis of Quality Indicators in CKD.
Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
[TBL] [Abstract][Full Text] [Related]
12. Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.
Gonçalves AR; Khwaja A; Ahmed AK; El Kossi M; El Nahas M
Nephron Clin Pract; 2011; 119(4):c348-54. PubMed ID: 22135795
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
Omae K; Ogawa T; Nitta K
Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
[TBL] [Abstract][Full Text] [Related]
14. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
[TBL] [Abstract][Full Text] [Related]
15. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Weir MR; Rolfe M
Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
[TBL] [Abstract][Full Text] [Related]
16. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of the utilization of angiotensin receptor blockers in hypertension].
Peña Cabia S; Ricote Lobera I; Santos Mena B; Hidalgo Correas FJ; Climent Florez B; García Díaz B
Farm Hosp; 2013; 37(5):394-8. PubMed ID: 24128102
[TBL] [Abstract][Full Text] [Related]
18. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
19. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
Farag A; Garg AX; Li L; Jain AK
Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
[TBL] [Abstract][Full Text] [Related]
20. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
Tiwari A; Tseng CL; Kern EF; Maney M; Miller DR; Pogach L
Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
